ONK Therapeutics Employee Directory
Biotechnology ResearchGalway, Ireland11-50 Employees
ONK Therapeutics is a Galway-based biotechnology company focused on developing innovative cell therapies for cancer. It is advancing an off-the-shelf natural killer (NK) cell platform engineered to carry two targeting functions: a receptor against a tumor antigen and a TRAIL variant that activates death receptor signaling. This dual mechanism is intended to enhance tumor cell death by engaging both intrinsic and extrinsic apoptotic pathways and to reduce the likelihood of tumor antigen escape. Founded in 2015 by Prof. O’Dwyer of NUI Galway, the company concentrates on hematological malignancies and solid tumors. It operates with a compact, specialized team. In 2023, ONK Therapeutics entered licensing agreements to support further development of its cell-based therapies.